Global Rapid Antigen Testing Market Research Report 2023

Publication ID:

PB502236821

Publication Date:

February 28, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Highlights
The global Rapid Antigen Testing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Rapid Antigen Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Rapid Antigen Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Rapid Antigen Testing in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Rapid Antigen Testing include Abbott Laboratories, F. Hoffmann-La Roche, Oxford BioMedica, Affinity Biologicals, Epitope Diagnostics, Sino Biological, R-Biopharma, Cell Biolabs and Thermo Fisher Scientific, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Rapid Antigen Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rapid Antigen Testing.
The Rapid Antigen Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Rapid Antigen Testing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rapid Antigen Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Abbott Laboratories
F. Hoffmann-La Roche
Oxford BioMedica
Affinity Biologicals
Epitope Diagnostics
Sino Biological
R-Biopharma
Cell Biolabs
Thermo Fisher Scientific
Bio-Rad Laboratories
Segment by Type
Immunosorbent Assay
Enzyme-linked Immunosorbent
Precipitation Reaction
Radioimmunoassay
Agglutination Reaction
Complement Fixatio
Segment by Application
Hospitals
Specialty Clinics
Diagnostic Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rapid Antigen Testing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rapid Antigen Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Immunosorbent Assay
1.2.3 Enzyme-linked Immunosorbent
1.2.4 Precipitation Reaction
1.2.5 Radioimmunoassay
1.2.6 Agglutination Reaction
1.2.7 Complement Fixatio
1.3 Market by Application
1.3.1 Global Rapid Antigen Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rapid Antigen Testing Market Perspective (2018-2029)
2.2 Rapid Antigen Testing Growth Trends by Region
2.2.1 Global Rapid Antigen Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Rapid Antigen Testing Historic Market Size by Region (2018-2023)
2.2.3 Rapid Antigen Testing Forecasted Market Size by Region (2024-2029)
2.3 Rapid Antigen Testing Market Dynamics
2.3.1 Rapid Antigen Testing Industry Trends
2.3.2 Rapid Antigen Testing Market Drivers
2.3.3 Rapid Antigen Testing Market Challenges
2.3.4 Rapid Antigen Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rapid Antigen Testing Players by Revenue
3.1.1 Global Top Rapid Antigen Testing Players by Revenue (2018-2023)
3.1.2 Global Rapid Antigen Testing Revenue Market Share by Players (2018-2023)
3.2 Global Rapid Antigen Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rapid Antigen Testing Revenue
3.4 Global Rapid Antigen Testing Market Concentration Ratio
3.4.1 Global Rapid Antigen Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rapid Antigen Testing Revenue in 2022
3.5 Rapid Antigen Testing Key Players Head office and Area Served
3.6 Key Players Rapid Antigen Testing Product Solution and Service
3.7 Date of Enter into Rapid Antigen Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rapid Antigen Testing Breakdown Data by Type
4.1 Global Rapid Antigen Testing Historic Market Size by Type (2018-2023)
4.2 Global Rapid Antigen Testing Forecasted Market Size by Type (2024-2029)
5 Rapid Antigen Testing Breakdown Data by Application
5.1 Global Rapid Antigen Testing Historic Market Size by Application (2018-2023)
5.2 Global Rapid Antigen Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Rapid Antigen Testing Market Size (2018-2029)
6.2 North America Rapid Antigen Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Rapid Antigen Testing Market Size by Country (2018-2023)
6.4 North America Rapid Antigen Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rapid Antigen Testing Market Size (2018-2029)
7.2 Europe Rapid Antigen Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Rapid Antigen Testing Market Size by Country (2018-2023)
7.4 Europe Rapid Antigen Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rapid Antigen Testing Market Size (2018-2029)
8.2 Asia-Pacific Rapid Antigen Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Rapid Antigen Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Rapid Antigen Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rapid Antigen Testing Market Size (2018-2029)
9.2 Latin America Rapid Antigen Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Rapid Antigen Testing Market Size by Country (2018-2023)
9.4 Latin America Rapid Antigen Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rapid Antigen Testing Market Size (2018-2029)
10.2 Middle East & Africa Rapid Antigen Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Rapid Antigen Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Rapid Antigen Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Rapid Antigen Testing Introduction
11.1.4 Abbott Laboratories Revenue in Rapid Antigen Testing Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Detail
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Rapid Antigen Testing Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Rapid Antigen Testing Business (2018-2023)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Oxford BioMedica
11.3.1 Oxford BioMedica Company Detail
11.3.2 Oxford BioMedica Business Overview
11.3.3 Oxford BioMedica Rapid Antigen Testing Introduction
11.3.4 Oxford BioMedica Revenue in Rapid Antigen Testing Business (2018-2023)
11.3.5 Oxford BioMedica Recent Development
11.4 Affinity Biologicals
11.4.1 Affinity Biologicals Company Detail
11.4.2 Affinity Biologicals Business Overview
11.4.3 Affinity Biologicals Rapid Antigen Testing Introduction
11.4.4 Affinity Biologicals Revenue in Rapid Antigen Testing Business (2018-2023)
11.4.5 Affinity Biologicals Recent Development
11.5 Epitope Diagnostics
11.5.1 Epitope Diagnostics Company Detail
11.5.2 Epitope Diagnostics Business Overview
11.5.3 Epitope Diagnostics Rapid Antigen Testing Introduction
11.5.4 Epitope Diagnostics Revenue in Rapid Antigen Testing Business (2018-2023)
11.5.5 Epitope Diagnostics Recent Development
11.6 Sino Biological
11.6.1 Sino Biological Company Detail
11.6.2 Sino Biological Business Overview
11.6.3 Sino Biological Rapid Antigen Testing Introduction
11.6.4 Sino Biological Revenue in Rapid Antigen Testing Business (2018-2023)
11.6.5 Sino Biological Recent Development
11.7 R-Biopharma
11.7.1 R-Biopharma Company Detail
11.7.2 R-Biopharma Business Overview
11.7.3 R-Biopharma Rapid Antigen Testing Introduction
11.7.4 R-Biopharma Revenue in Rapid Antigen Testing Business (2018-2023)
11.7.5 R-Biopharma Recent Development
11.8 Cell Biolabs
11.8.1 Cell Biolabs Company Detail
11.8.2 Cell Biolabs Business Overview
11.8.3 Cell Biolabs Rapid Antigen Testing Introduction
11.8.4 Cell Biolabs Revenue in Rapid Antigen Testing Business (2018-2023)
11.8.5 Cell Biolabs Recent Development
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Detail
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific Rapid Antigen Testing Introduction
11.9.4 Thermo Fisher Scientific Revenue in Rapid Antigen Testing Business (2018-2023)
11.9.5 Thermo Fisher Scientific Recent Development
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Detail
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories Rapid Antigen Testing Introduction
11.10.4 Bio-Rad Laboratories Revenue in Rapid Antigen Testing Business (2018-2023)
11.10.5 Bio-Rad Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Abbott Laboratories
F. Hoffmann-La Roche
Oxford BioMedica
Affinity Biologicals
Epitope Diagnostics
Sino Biological
R-Biopharma
Cell Biolabs
Thermo Fisher Scientific
Bio-Rad Laboratories

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂